These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 35323359

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Enhanced Masses on Contrast-Enhanced Breast: Differentiation Using a Combination of Dynamic Contrast-Enhanced MRI and Quantitative Evaluation with Synthetic MRI.
    Matsuda M, Tsuda T, Ebihara R, Toshimori W, Takeda S, Okada K, Nakasuka K, Shiraishi Y, Suekuni H, Kamei Y, Kurata M, Kitazawa R, Mochizuki T, Kido T.
    J Magn Reson Imaging; 2021 Feb; 53(2):381-391. PubMed ID: 32914921
    [Abstract] [Full Text] [Related]

  • 26. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
    Gity M, Parviz S, Saligheh Rad H, Fathi Kazerooni A, Shirali E, Shakiba M, Baikpour M.
    Asian Pac J Cancer Prev; 2019 Apr 29; 20(4):1073-1079. PubMed ID: 31030476
    [Abstract] [Full Text] [Related]

  • 27. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
    Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, Plecha D, Madabhushi A.
    Breast Cancer Res; 2017 May 18; 19(1):57. PubMed ID: 28521821
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies.
    Pötsch N, Dietzel M, Kapetas P, Clauser P, Pinker K, Ellmann S, Uder M, Helbich T, Baltzer PAT.
    Eur Radiol; 2021 Aug 18; 31(8):5866-5876. PubMed ID: 33744990
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Breast Cancer Classification on Multiparametric MRI - Increased Performance of Boosting Ensemble Methods.
    Vamvakas A, Tsivaka D, Logothetis A, Vassiou K, Tsougos I.
    Technol Cancer Res Treat; 2022 Aug 18; 21():15330338221087828. PubMed ID: 35341421
    [Abstract] [Full Text] [Related]

  • 36. Artificial Intelligence-Based Classification of Breast Lesions Imaged With a Multiparametric Breast MRI Protocol With Ultrafast DCE-MRI, T2, and DWI.
    Dalmiş MU, Gubern-Mérida A, Vreemann S, Bult P, Karssemeijer N, Mann R, Teuwen J.
    Invest Radiol; 2019 Jun 18; 54(6):325-332. PubMed ID: 30652985
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Robustness of radiomic features of benign breast lesions and hormone receptor positive/HER2-negative cancers across DCE-MR magnet strengths.
    Whitney HM, Drukker K, Edwards A, Papaioannou J, Medved M, Karczmar G, Giger ML.
    Magn Reson Imaging; 2021 Oct 18; 82():111-121. PubMed ID: 34174331
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.